Drug-resistant swine flu cases discovered in patients in Seattle

August 16, 2009 By Sandi Doughton

The country's first cases of drug-resistant swine flu were discovered in two leukemia patients in Seattle, the U.S. Centers for Disease Control and Prevention reported Friday.

Both patients, who had weakened immune systems from and stem-cell transplants, developed flu strains resistant to the anti-viral drug oseltamivir, sold as .

There was no connection between the cases and no threat to the public, said Dr. Jeff Duchin, chief of communicable-disease control for Public Health-Seattle & King County. None of the patients' family members, or the health workers who cared for them, contracted the disease.

The Seattle cases bring to 11 the worldwide total of people diagnosed with Tamiflu-resistant infections of the H1N1 virus.

"These are rare, isolated types of phenomena," Duchin said. "It's not something we expect is going to lead to widespread drug resistance in the community."

But the cases underscore the need for judicious use of anti-viral drugs to ensure resistant strains do not become more common, he said.

Last month, CDC officials warned summer camps to stop the practice of handing out Tamiflu to healthy children in an effort to ward off infection.

"Anti-viral drugs should be used to treat an infection after it's occurred -- once the cat is out of the bag," Duchin said. "The more promiscuous use ... the more chances we have to develop resistant viruses."

Patients with weakened immune systems are most vulnerable because their bodies are not able to join forces with the drugs to fight off the virus. That means the virus persists longer in the presence of the anti-viral drugs, which is a recipe for the evolution of drug-resistant bugs.

One of the patients is a teenage boy who received a stem-cell transplant in May. He contracted the flu virus later that month and has since recovered.

The second patient, a woman in her 40s who relapsed after an earlier stem-cell transplant, remains hospitalized.

Genetic analysis showed that over several weeks of Tamiflu treatment, the flu bugs in their bodies mutated and were no longer sensitive to the drug.

The account of the cases, published in CDC's Morbidity and Mortality Weekly Report, identifies the hospitals as Seattle Children's and the University of Washington Medical Center.

Local and state health officials are working with the CDC to boost monitoring for drug-resistant viruses.
___

(c) 2009, The Seattle Times.
Visit The Seattle Times Extra on the World Wide Web at www.seattletimes.com/
Distributed by McClatchy-Tribune Information Services.

Related Stories

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.